磷酸托西拉尼（帕拉迪）辅助化疗治疗猫眼眶限制性肌成纤维细胞肉瘤：一例猫的病例研究
Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat.
作者信息
Komatsu Hiroyuki, Ueshima Asuka, Kobayashi Yoshitaka, Shimoyama Yumiko, Takiyama Naoaki, Rimpo Kenji
机构信息
Animal Eye Care-Tokyo Animal Eye Clinic Tokyo Japan.
Saitama Animal Medical Center Saitama Japan.
出版信息
Clin Case Rep. 2023 Jun 17;11(6):e7582. doi: 10.1002/ccr3.7582. eCollection 2023 Jun.
KEY CLINICAL MESSAGE
This is the first case report of treatment with toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS. This reported case highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS.
ABSTRACT
Feline restrictive orbital myofibroblastic sarcoma (FROMS) is a rare aggressive tumor in cats. We explored the effectiveness of using toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS in a 7-year-old cat. Despite treatment, the cat died 4 months after surgery. This report highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS.
关键临床信息
这是首例使用磷酸托西拉尼作为晚期猫眼眶限制性肌纤维母细胞肉瘤（FROMS）术后辅助化疗的病例报告。该病例报告强调了有必要进一步研究磷酸托西拉尼作为FROMS辅助化疗的疗效。
摘要
猫眼眶限制性肌纤维母细胞肉瘤（FROMS）是猫中一种罕见的侵袭性肿瘤。我们探讨了在一只7岁猫中使用磷酸托西拉尼作为晚期FROMS术后辅助化疗的有效性。尽管进行了治疗，这只猫在手术后4个月死亡。本报告强调了有必要进一步研究磷酸托西拉尼作为FROMS辅助化疗的疗效。
Zotero 插件